20/20 Biolabs Seeks Authorization for Up to 1-for-250 Reverse Split to Regain Nasdaq Compliance
AIDX is trading near its 52-week low of $0.331 (5.7% above the low).
Summary
20/20 Biolabs is seeking shareholder approval for a reverse stock split of up to 1-for-250 to regain Nasdaq's $1.00 minimum bid price compliance. The special meeting is set for December 9, 2026.
Key Events · Corporate Governance and Compliance · AIDX
-
Reverse Split Authorization Sought
Proposal 1 asks shareholders to authorize the board to implement one or more reverse stock splits at a cumulative ratio of not less than 1-for-2 and not more than 1-for-250 at any time prior to December 31, 2028.
-
Nasdaq Compliance Deadline
The company received a Nasdaq delisting notice on July 17, 2026 for failing the $1.00 bid price rule and has until January 13, 2027 to regain compliance; a second deficiency notice for stockholders' equity was issued on September 10, 2026.
-
Special Meeting Scheduled
The special meeting of stockholders will be held virtually on December 9, 2026 at 10:00 a.m. Eastern Time.
-
Board Discretion on Ratio and Timing
The board may choose the specific reverse split ratio and may delay implementation until December 31, 2028, based on market conditions and other factors.
Analysis · AIDX · Industrial Applications And Services
The company is asking shareholders to approve a reverse stock split of up to 1-for-250 to lift its stock price above Nasdaq's $1.00 minimum bid requirement. The stock currently trades at $0.35, and the company has until January 13, 2027 to regain compliance. A reverse split would reduce the share count and mechanically raise the price, but it does not change the company's market value or fix its underlying financial problems. The board wants broad discretion to choose the ratio and timing, which gives it flexibility but also creates uncertainty for shareholders. This is a critical governance event because failure to regain compliance could lead to delisting, which would severely reduce liquidity and access to capital.
How filings like this one have moved
In the 30 days to Oct 6, 2026, 36.5% of the 1012 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AIDX was trading at $0.35 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.5M. The 52-week trading range was $0.33 to $50.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.